Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Operating Leases (2019 - 2025)

Veracyte (VCYT) has disclosed Operating Leases for 7 consecutive years, with $39.7 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 8.29% to $39.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.7 million through Dec 2025, down 8.29% year-over-year, with the annual reading at $39.7 million for FY2025, 8.29% down from the prior year.
  • Operating Leases hit $39.7 million in Q4 2025 for Veracyte, down from $40.5 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $50.6 million in Q2 2025 to a low of $7.5 million in Q4 2023.
  • Historically, Operating Leases has averaged $21.0 million across 5 years, with a median of $14.1 million in 2021.
  • Biggest YoY gain for Operating Leases was 474.58% in 2024; the steepest drop was 41.55% in 2024.
  • Year by year, Operating Leases stood at $14.1 million in 2021, then decreased by 24.46% to $10.6 million in 2022, then fell by 29.33% to $7.5 million in 2023, then surged by 474.58% to $43.2 million in 2024, then fell by 8.29% to $39.7 million in 2025.
  • Business Quant data shows Operating Leases for VCYT at $39.7 million in Q4 2025, $40.5 million in Q3 2025, and $50.6 million in Q2 2025.